Pharmafile Logo

Jenzyme Consulting Associates

Jenzyme Consulting Associates is a UK-based company, which was established in 1996 and which specialises in consultancy on sales and marketing issues and management skill training, primarily in the healthcare industry. All partners and associate consultants have gained extensive international sales and marketing management, strategic planning and management consulting experience working for large multinational pharmaceutical companies.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

AMICULUM

AMICULUM is an independent family of 11 branded agencies that deliver communications and consultancy services to pharmaceutical, biotechnology and health technology companies across the world. What makes us different is…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

7 Shires Way, Yateley, Hampshire, GU46 7SX, United Kingdom
+44 (0)1252 874234

 Latest Content from PMHub 

Free Live Webinar – Uniting Communities for Rare Disease Clinical Trial Success

Join this live webinar focusing on patient recruitment and retention in rare disease trials.

TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH

It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of...

Hope in cancer therapy

The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.

Health awareness days in May

Are you marketing to clinical audiences around upcoming health awareness days?

Why Women in Medicine Should Embrace Social Media

Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming communities, fighting misinformation, amplifying one another, and galvanizing...

Exceptional Impact Presented at ECCMID 2024

The ECCMID conference in Barcelona, Spain marked the start of Medscape’s publication season in Europe. With three posters being presented at the conference, Medscape shared highlights from the powerful impact...

The role of economic evaluation in US healthcare

Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight important considerations for companies seeking...

How to successfully manage change and enable digital transformation within pharma

Press Releases | April 30, 2024 | Graphite Digital

Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...

Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...